Elsevier Blinks, Will No Longer Support Research Works Act

In a victory for science, and those who favor open access for the easy dissemination of scientific results to the public and scientists around the world, Elsevier has withdrawn support for the Research Works Act.

I think credit has to go to Tim Gowers calling for and Michael Eisen spreading the word on the boycott and getting Elsevier's attention. Eisen initially brought our attention to the bill which would have allowed Elsevier to break with the growing tendency towards putting science payed for with tax dollars into open access databases. The Research Works Act would allow them to erect pay walls on publicly-funded research and it was out of line with where science publishing has been going for the last decade. By calling attention to it and pushing back against Elsevier, the publisher that seemed to be largely behind the new legislation, Gowers and Eisen appear to have effectively killed support for this bill. If congress gets the message hopefully it will sink into oblivion.

We have to be vigilant for future efforts to restrict open access such as this bill. After the public spends millions on individual research projects, scientists spend years making discoveries, and peer reviewers donate their time to critique and improve the presentation of the data in the manuscripts, it's exceedingly arrogant that publishers feel they own those results for decades just because they came in at the end as the publisher. While publishing is a capitalist enterprise and they should make money, their compensation should be proportionate to the effort and investment they put into the manuscript. The reality is, their contribution is vanishingly small compared to the efforts of scientists and costs to taxpayers. With the expansion of online databases, the decreasing costs of distribution of information, and the role of the internet in science communication, they can no longer justify their strangle hold on scientific results for decades after initial publication.

More like this

This post has superseded my two previous link collection posts here and here. The first focused solely on the Research Works Act, the second added posts on the Elsevier boycott and this one also incorporates posts on the reintroduction of The Federal Research Public Access Act. These three…
Note: this post is superseded by: Around the Web: Research Works Act, Elsevier boycott & FRPAA. This post has superseded my previous post which focused solely on the Research Works Act. I have added some coverage of the Elsevier boycott which at least partially grew out of opposition to the…
At It's not junk Michael Eisen continues to expose the shameless actions of Carolyn Maloney to sell out science for the sake of publishers like Elsevier. As we remarked last week, it seems that very little money is required to buy a representatives favor towards your industry, even if that means…
Note: this post is superseded by: Around the Web: Research Works Act, Elsevier boycott & FRPAA. Following on my post from yesterday on Scholarly Societies: It's time to abandon the AAP over The Research Works Act, I thought I'd gather together some of the recent posts on the issue. The…

The current boycott was actually launched by Tim Gowers, not Mike Eisen, though of course Eisen has been on the frontlines of the struggle for open access for a long time.

It's highly probable that Elsevier will renew it's attempt at some future date, either when they think no one is watching, or through some alternate means which they believe they can keep secret. This should serve as a wake up call: "That terminator is out there. It can't be bargained with. It can't be reasoned with. It doesn't feel pity, or remorse, or fear. And it absolutely will not stop, ever, until ..."

The only real way to stop Elsevier is to render it irrelevant. To that extent, Elsevier has done a service by showing the need for alternate, open means of communication which are managed by the content contributors and not by disconnected publishers with only their own interests in mind.

The move away from Elsevier and its ilk should continue.